Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
These compounds directly influence intestinal cells to enhance natural GLP-1 release, creating a foundation for improved metabolic function
doi:10.1016/S0140-6736(19)31149-3
Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial [published correction appears in Lancet
Conversely, the same analysis found no difference in weight loss for exenatide once weekly or liraglutide between patients experiencing gastrointestinal adverse events and those with none in DURATION-6 [52]
2020;17:35 Rossi F, Lewis C
US$ 25.49
US$ 24.33
US$ 29.65
US$ 22.83
US$ 29.46
US$ 20.15
US$ 29.59
US$ 21.62
US$ 20.88
